The current STATe of biomarkers to predict the response to anti-angiogenic therapies

被引：2
|
作者：
Tran, Phuoc T. [1 ,2 ,3 ]
Felsher, Dean W. [1 ,2 ]
机构：
[1] Stanford Univ, Sch Med, Dept Pathol, Div Oncol, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Med, Div Oncol, Stanford, CA 94305 USA
[3] Stanford Univ, Sch Med, Dept Radiat Oncol, Div Oncol, Stanford, CA 94305 USA
来源：
CANCER BIOLOGY & THERAPY | 2008年 / 7卷 / 12期
关键词：
VEGFR2; STAT3; Src; signaling; tissue biomarker; angiogenesis; anti-angiogenic;
D O I：
10.4161/cbt.7.12.7191
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2004 / 2006
页数：3
相关论文
共 50 条
  • [1] Biomarkers in the development of anti-angiogenic therapies for ovarian cancer
    Raja, Fharat A.
    Hook, Jane M.
    Ledermann, Jonathan A.
    CANCER TREATMENT REVIEWS, 2012, 38 (06) : 662 - 672
  • [2] Responses to anti-angiogenic therapies
    Paller, AS
    JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, 2000, 5 (01) : 83 - 86
  • [3] Nephrotoxicity of Anti-Angiogenic Therapies
    Van Wynsberghe, Margaux
    Flejeo, Joanne
    Sakhi, Hamza
    Ollero, Mario
    Sahali, Dil
    Izzedine, Hassan
    Henique, Carole
    DIAGNOSTICS, 2021, 11 (04)
  • [4] Current status and future prospects for anti-angiogenic therapies in cancer
    Staton, Carolyn A.
    Brown, Nicola J.
    Reed, Malcolm W. R.
    EXPERT OPINION ON DRUG DISCOVERY, 2009, 4 (09) : 961 - 979
  • [5] Current and emerging anti-angiogenic therapies in gastrointestinal and hepatobiliary cancers
    Saoudi Gonzalez, Nadia
    Castet, Florian
    elez, Elena
    Macarulla, Teresa
    Tabernero, Josep
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [6] BIOMARKERS FOR ANTI-ANGIOGENIC THERAPY
    Das, Millie
    Wakelee, Heather
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S442 - S443
  • [7] Predicting response to anti-angiogenic therapies: focus on genetic susceptibility to response
    Lambrechts, Diether
    ANGIOGENESIS, 2014, 17 (03) : 727 - 727
  • [8] Is the toxicity of anti-angiogenic drugs predictive of outcome? A review of hypertension and proteinuria as biomarkers of response to anti-angiogenic therapy
    Horsley, Laura
    Marti, Kalena
    Jayson, Gordon C.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2012, 8 (03) : 283 - 293
  • [9] Anti-angiogenic therapies in brain metastases
    Berghoff A.S.
    Preusser M.
    memo - Magazine of European Medical Oncology, 2018, 11 (1) : 14 - 17
  • [10] Anti-angiogenic therapies and hemorrhagic risk
    Ayllon, J.
    Pignot, G.
    PROGRES EN UROLOGIE, 2010, 20 : S20 - S22
12345